Open main menu
Home
Random
Recent changes
Special pages
Community portal
Preferences
About Wikipedia
Disclaimers
Incubator escapee wiki
Search
User menu
Talk
Dark mode
Contributions
Create account
Log in
Editing
Clonal anergy
(section)
Warning:
You are not logged in. Your IP address will be publicly visible if you make any edits. If you
log in
or
create an account
, your edits will be attributed to your username, along with other benefits.
Anti-spam check. Do
not
fill this in!
==Dominant tolerance== Dominant and recessive tolerance are forms of a [[peripheral tolerance]] (the other tolerance beside peripheral is a [[central tolerance]]). Where so called recessive tolerance is associated with anergized lymphocytes as described above, in the dominant form of tolerance, specialized [[Regulatory T cell|T-reg cells]] which actively ablate the immune response are developed from the naive [[T cell|T lymphocyte]]. Similarly to recessive tolerance, unopposed [[NFAT]] signalling is also important for [[Regulatory T cell|T-reg]] induction. In this case, the [[NFAT]] pathway activates another transcription factor β [[FOXP3]]<ref name="Tone et al">{{cite journal | vauthors = Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M | title = Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer | journal = Nature Immunology | volume = 9 | issue = 2 | pages = 194β202 | date = February 2008 | pmid = 18157133 | doi = 10.1038/ni1549 | s2cid = 7005085 }}</ref> that is a marker of [[Regulatory T cell|T-regs]] and participates in their genetic program.<ref name="Rudensky et al"/><ref name="Hermann-Kleiter N. and Baier G.">{{cite journal | vauthors = Hermann-Kleiter N, Baier G | title = NFAT pulls the strings during CD4+ T helper cell effector functions | journal = Blood | volume = 115 | issue = 15 | pages = 2989β2997 | date = April 2010 | pmid = 20103781 | doi = 10.1182/blood-2009-10-233585 | doi-access = free }}</ref>
Edit summary
(Briefly describe your changes)
By publishing changes, you agree to the
Terms of Use
, and you irrevocably agree to release your contribution under the
CC BY-SA 4.0 License
and the
GFDL
. You agree that a hyperlink or URL is sufficient attribution under the Creative Commons license.
Cancel
Editing help
(opens in new window)